Cellular immunotherapy studies and immune effector cell therapies
Published on 06 April 2021
We provide cell collection procedures for cellular immunotherapy studies and immune effector cell therapies.
This is a rapidly developing area, with patient treatments coming into routine clinical practice through clinical trials.
All referrals for these procedures as part of the patient's standard treatment plan are managed through our local clinical apheresis units.
All referrals for these procedures within a clinical trial are coordinated by our colleagues in our Tissues, Cells and Advanced Therapies, and Business Development divisions and our local clincal apheresis units.
Contact your local apheresis unit to find out more about collections for clinical programmes and clinical trials.